Myriad Genetics Inc (MYGN)

Total asset turnover

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Revenue (ttm)	US$ in thousands	794,900	766,400	745,400	731,500	696,200	691,900	675,200	820,600	831,200	839,900	846,300	666,200	590,100	564,400	586,600	627,900	750,000	801,700	822,500	840,100
Total assets	US$ in thousands	1,085,100	1,110,500	1,146,500	1,149,100	1,187,200	1,169,300	1,198,700	1,212,000	1,210,200	1,255,400	1,320,700	1,335,900	1,360,300	1,336,900	1,444,500	1,404,600	1,446,700	1,578,300	1,591,200	1,562,700
Total asset turnover		0.73	0.69	0.65	0.64	0.59	0.59	0.56	0.68	0.69	0.67	0.64	0.50	0.43	0.42	0.41	0.45	0.52	0.51	0.52	0.54

June 30, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $794,900K ÷ $1,085,100K
= 0.73

The total asset turnover ratio for Myriad Genetics Inc has shown fluctuations over the past few quarters. The ratio has ranged from 0.41 to 0.73, indicating the company's ability to generate revenue from its assets has varied. A higher total asset turnover ratio typically indicates more efficient asset utilization and revenue generation.

Myriad Genetics Inc's total asset turnover has generally trended upwards since September 2021, with some fluctuations in between. However, the ratio has not consistently increased, suggesting potential challenges or changes in the company's operations impacting its ability to efficiently utilize assets to generate revenue.

Further analysis and comparison with industry benchmarks or competitors would provide additional insights into Myriad Genetics Inc's performance in terms of asset efficiency and revenue generation.